苑东生物
(688513)
| 流通市值：90.31亿 | | | 总市值：90.31亿 |
| 流通股本：1.77亿 | | | 总股本：1.77亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 658,897,905.28 | 326,262,896.49 | 1,331,390,248.33 | 1,019,133,615.33 |
| 营业总成本 | 569,884,268.06 | 295,762,658.95 | 1,122,067,149.82 | 830,690,066.9 |
| 其他经营收益 | | | | |
| 营业利润 | 132,808,499.73 | 47,361,946.72 | 314,630,247.51 | 241,755,591.93 |
| 利润总额 | 134,240,093.13 | 47,401,262.93 | 299,651,029.1 | 242,089,808.95 |
| 净利润 | 112,103,602.37 | 43,281,766.32 | 273,573,868.43 | 220,162,482.66 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | 112,103,602.37 | 43,281,766.32 | 273,573,868.43 | 220,162,482.66 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 2,162,045,387.77 | 2,117,374,283.67 | 2,132,164,292.56 | 2,075,169,166.49 |
| 非流动资产: | | | | |
| 非流动资产合计 | 1,662,133,480.35 | 1,660,070,269.89 | 1,665,715,014.65 | 1,483,752,866.61 |
| 资产总计 | 3,824,178,868.12 | 3,777,444,553.56 | 3,797,879,307.21 | 3,558,922,033.1 |
| 流动负债: | | | | |
| 流动负债合计 | 665,666,021.73 | 553,638,224.97 | 618,696,725.44 | 593,267,342.68 |
| 非流动负债: | | | | |
| 非流动负债合计 | 136,752,723.83 | 137,849,145.31 | 140,207,073.79 | 99,673,628.72 |
| 负债合计 | 802,418,745.56 | 691,487,370.28 | 758,903,799.23 | 692,940,971.4 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 2,933,271,121.34 | 2,987,369,133.16 | 2,932,838,202.3 | 2,865,981,061.7 |
| 股东权益合计 | 3,021,760,122.56 | 3,085,957,183.28 | 3,038,975,507.98 | 2,865,981,061.7 |
| 负债和股东权益合计 | 3,824,178,868.12 | 3,777,444,553.56 | 3,797,879,307.21 | 3,558,922,033.1 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 803,415,094.68 | 410,262,365.73 | 1,513,255,802.36 | 1,159,913,582.8 |
| 经营活动现金流出小计 | 636,018,833.62 | 314,706,795.06 | 1,248,314,598.14 | 941,095,392.1 |
| 经营活动产生的现金流量净额 | 167,396,261.06 | 95,555,570.67 | 264,941,204.22 | 218,818,190.7 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 738,593,251.48 | 425,123,849.69 | 1,331,819,177.43 | 626,626,627.23 |
| 投资活动现金流出小计 | 1,357,847,407.46 | 978,742,257.77 | 1,698,271,036.18 | 1,212,819,804.56 |
| 投资活动产生的现金流量净额 | -619,254,155.98 | -553,618,408.08 | -366,451,858.75 | -586,193,177.33 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 124,506,959.23 | 8,289,443.67 | 205,510,482.41 | 180,286,944.98 |
| 筹资活动现金流出小计 | 229,113,908.02 | 74,559,786.21 | 231,829,982.87 | 217,893,558.48 |
| 筹资活动产生的现金流量净额 | -104,606,948.79 | -66,270,342.54 | -26,319,500.46 | -37,606,613.5 |
| 汇率变动对现金及现金等价物的影响 | -1,063,542.42 | -423,703.76 | -470,178.96 | -194,430.1 |
| 现金及现金等价物净增加额 | -557,528,386.13 | -524,756,883.71 | -128,300,333.95 | -405,176,030.23 |
| 期末现金及现金等价物余额 | 279,349,785.11 | 312,121,287.53 | 836,878,171.24 | 560,002,474.96 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -557,528,386.13 | - | -128,300,333.95 | - |
最新报告期：2026-09-17| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 西部证券 | 李梦园 | 1.68 | 1.88 | 2.12 | 2026-09-17 |
| 华源证券 | 刘闯 | 1.59 | 1.77 | 2.05 | 2026-09-13 |
| 浙商证券 | 盖文化,郭双喜 | 1.62 | 1.78 | 2.03 | 2026-08-26 |
| 东吴证券 | 朱国广 | 1.64 | 1.81 | 2.01 | 2026-08-24 |
| 中信建投 | 沈毅,袁清慧 | 1.47 | 1.68 | 1.97 | 2026-08-22 |